BioWorld MedTech

March 27, 2013

View Archived Issues

AdreView approved for risk evaluation in HF patients

GE Healthcare (Princeton, New Jersey) reported FDA approval of a new indication for AdreView (Iobenguane I 123 Injection), a molecular imaging agent, to link nerve function in the heart to a patient's mortality risk. Read More

Johns Hopkins students develop simple, effective cooling device

Read More

Report from Europe: Miracor treats German patient with PICSO

Read More

Washington roundup: McConnell to House; vote on stand-alone device tax repeal

Read More

Agreements/contracts: PrimeraDx to co-develop diagnostics with Quest

Read More

Deals roundup: ICCNexergy in plan to acquire Applied Power

Read More

HIT roundup: TGen tests secure connection using Obsidian's Longbow tech

Read More

Financings roundup: Medgenics reports exercise of over-allotment option

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Oncology Extra

Read More